% alzhub.org library filter
% Source: https://alzhub.org/research?author=Videla+L&access=free
% 11 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{fortea2024-38710950,
  author  = {Fortea, J. and Pegueroles, J. and Alcolea, D. and Belbin, O. and Dols-Icardo, O. and Vaqué-Alcázar, L. and Videla, L. and Gispert, J. D. and others},
  title   = {{APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02931-w},
  pmid    = {38710950},
  url     = {https://doi.org/10.1038/s41591-024-02931-w}
}

@article{videla2025-40528282,
  author  = {Videla, L. and Benejam, B. and Barroeta, I. and Fernandez, S. and Altuna, M. and Arranz, J. and Í, Rodríguez-Baz and Arriola-Infante, J. E. and others},
  title   = {{The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70259},
  pmid    = {40528282},
  url     = {https://doi.org/10.1002/alz.70259}
}

@article{videla2022-35930282,
  author  = {Videla, L. and Benejam, B. and Pegueroles, J. and Carmona-Iragui, M. and Padilla, C. and Fernández, S. and Barroeta, I. and Altuna, M. and others},
  title   = {{Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome}},
  journal = {JAMA network open},
  year    = {2022},
  doi     = {10.1001/jamanetworkopen.2022.25573},
  pmid    = {35930282},
  url     = {https://doi.org/10.1001/jamanetworkopen.2022.25573}
}

@article{bejanin2021-34228042,
  author  = {Bejanin, A. and Iulita, M. F. and Vilaplana, E. and Carmona-Iragui, M. and Benejam, B. and Videla, L. and Barroeta, I. and Fernandez, S. and others},
  title   = {{Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome}},
  journal = {JAMA neurology},
  year    = {2021},
  doi     = {10.1001/jamaneurol.2021.1893},
  pmid    = {34228042},
  url     = {https://doi.org/10.1001/jamaneurol.2021.1893}
}

@article{huber2025-41213934,
  author  = {Huber, H. and Arranz, J. and Arslan, B. and Leuzy, A. and Kittel, O. and di Molfetta, G. and Benejam, B. and Videla, L. and others},
  title   = {{Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome}},
  journal = {Nature communications},
  year    = {2025},
  doi     = {10.1038/s41467-025-65882-x},
  pmid    = {41213934},
  url     = {https://doi.org/10.1038/s41467-025-65882-x}
}

@article{belbin2020-32807227,
  author  = {Belbin, O. and Xiao, M. F. and Xu, D. and Carmona-Iragui, M. and Pegueroles, J. and Benejam, B. and Videla, L. and Fernández, S. and others},
  title   = {{Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome}},
  journal = {Molecular neurodegeneration},
  year    = {2020},
  doi     = {10.1186/s13024-020-00398-0},
  pmid    = {32807227},
  url     = {https://doi.org/10.1186/s13024-020-00398-0}
}

@article{pegueroles2018-30410669,
  author  = {Pegueroles, J. and Jiménez, A. and Vilaplana, E. and Montal, V. and Carmona-Iragui, M. and Pané, A. and Alcolea, D. and Videla, L. and others},
  title   = {{Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study}},
  journal = {Oncotarget},
  year    = {2018},
  doi     = {10.18632/oncotarget.26162},
  pmid    = {30410669},
  url     = {https://doi.org/10.18632/oncotarget.26162}
}

@article{cervantesgonzalez2026-42768868,
  author  = {Cervantes González, A. and Morcillo-Nieto, A. O. and Serrano, S. and Benejam, B. and Videla, L. and Barroeta, I. and Fernández, S. and Del Hoyo Soriano, L. and others},
  title   = {{Changes in serum β-synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71860},
  pmid    = {42768868},
  url     = {https://doi.org/10.1002/alz.71860}
}

@article{lleo2021-34183050,
  author  = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others},
  title   = {{VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00861-0},
  pmid    = {34183050},
  url     = {https://doi.org/10.1186/s13195-021-00861-0}
}

@article{carmonairagui2017-27858714,
  author  = {Carmona-Iragui, M. and Santos, T. and Videla, S. and Fernández, S. and Benejam, B. and Videla, L. and Alcolea, D. and Blennow, K. and others},
  title   = {{Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-160827},
  pmid    = {27858714},
  url     = {https://doi.org/10.3233/jad-160827}
}

@article{lleo2021-870cda97,
  author  = {Lleó, A. and Carmona-Iragui, M. and Videla, L. and Fernández, S. and Benejam, B. and Pegueroles, J. and Barroeta, I. and Altuna, M. and others},
  title   = {{VAMP-2 Is a Surrogate Cerebrospinal Fluid Marker of Alzheimer-related Cognitive Impairment in Adults With Down Syndrome}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.21203/rs.3.rs-340117/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-340117/v1}
}